A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia-Reference-Cited by-同舟云学术

A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia

Published:2014-10 Issue:2 Volume:80 Page:141-147
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Zhao Xu,Wu Ju-fang,Xiu Qing-yu,Wang Chen,Zhang De-ping,Huang Jian-an,Xie Can-mao,Sun Sheng-hua,Lv Xiao-ju,Si Bin,Xiao Zu-ke,Zhang Ying-yuan

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection;Anderson;Drugs,2008

2. Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization;Cao;J Clin Pharm Ther,2013

3. Practice of internal medicine (in Chinese);Chen,2005

4. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers;Chow;Antimicrob Agents Chemother,2001

5. Performance standards for antimicrobial susceptibility testing: 17th informational supplement (M100-S15);Clinical Laboratory Standards Institute (CLSI),2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study;Scientific Reports;2024-08-06

2. Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance—A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK;Pharmaceuticals;2024-03-06

3. Short-course antibiotics for common infections: what do we know and where do we go from here?;Clinical Microbiology and Infection;2023-02

4. Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV;Open Forum Infectious Diseases;2022-12-29

5. A systematic review of acute and emergency care interventions for adolescents and adults with severe acute respiratory infections including COVID-19 in low- and middle-income countries;Journal of Global Health;2022-11-08